A fourth patient of University College London Hospitals NHS Foundation Trust (UCLH) is to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD) following a ruling from the Court of Protection.
A fourth patient of University College London Hospitals NHS Foundation Trust (UCLH) is to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD) following a ruling from the Court of Protection.
Sign up to our mailing list to stay updated on our work, as well as donating, fundraising, volunteering and campaigning opportunities:
Website by AW Design